Peter Szeto

683 total citations
21 papers, 562 citations indexed

About

Peter Szeto is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Peter Szeto has authored 21 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 3 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Peter Szeto's work include Synthesis and Catalytic Reactions (12 papers), Asymmetric Synthesis and Catalysis (8 papers) and Chemical synthesis and alkaloids (8 papers). Peter Szeto is often cited by papers focused on Synthesis and Catalytic Reactions (12 papers), Asymmetric Synthesis and Catalysis (8 papers) and Chemical synthesis and alkaloids (8 papers). Peter Szeto collaborates with scholars based in United Kingdom, Switzerland and Russia. Peter Szeto's co-authors include Timothy Gallagher, John F. Bower, Robert A. Stockman, Alex Sinclair, David L. Hughes, R. Michael Lawrence, A. Williams, Jakub Švenda, T. Riis‐Johannessen and Andrew J. Whitehead and has published in prestigious journals such as Angewandte Chemie International Edition, Analytical Chemistry and Chemical Communications.

In The Last Decade

Peter Szeto

21 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Szeto United Kingdom 14 508 205 82 27 23 21 562
Brandi M. Hudson United States 11 266 0.5× 126 0.6× 52 0.6× 25 0.9× 7 0.3× 12 403
Jingyun Ren China 11 398 0.8× 71 0.3× 93 1.1× 13 0.5× 14 0.6× 18 483
Xiaobing Xu China 14 532 1.0× 57 0.3× 77 0.9× 39 1.4× 10 0.4× 19 777
Joachim Bialas Germany 4 422 0.8× 120 0.6× 31 0.4× 17 0.6× 32 1.4× 5 528
Peter S. Hynes United Kingdom 4 619 1.2× 156 0.8× 169 2.1× 41 1.5× 19 0.8× 4 638
Mark R. Fielding United Kingdom 13 474 0.9× 77 0.4× 77 0.9× 14 0.5× 14 0.6× 14 528
Vishal Jheengut Canada 11 651 1.3× 124 0.6× 126 1.5× 16 0.6× 16 0.7× 14 684
Anyu He United States 12 412 0.8× 84 0.4× 106 1.3× 14 0.5× 9 0.4× 17 446
Keith E. McCarthy United States 11 341 0.7× 137 0.7× 40 0.5× 18 0.7× 14 0.6× 19 401
U.V. Subba Reddy India 13 390 0.8× 113 0.6× 70 0.9× 18 0.7× 20 0.9× 27 425

Countries citing papers authored by Peter Szeto

Since Specialization
Citations

This map shows the geographic impact of Peter Szeto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Szeto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Szeto more than expected).

Fields of papers citing papers by Peter Szeto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Szeto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Szeto. The network helps show where Peter Szeto may publish in the future.

Co-authorship network of co-authors of Peter Szeto

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Szeto. A scholar is included among the top collaborators of Peter Szeto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Szeto. Peter Szeto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bream, Robert N., Hugh Clark, Antal Harsányi, et al.. (2021). Application of C–H Functionalization in the Development of a Concise and Convergent Route to the Phosphatidylinositol-3-kinase Delta Inhibitor Nemiralisib. Organic Process Research & Development. 25(3). 529–540. 11 indexed citations
2.
3.
Donohoe, Timothy J., et al.. (2011). A Short and Efficient Synthesis of Neodysiherbaine A by Using Catalytic Oxidative Cyclization. Angewandte Chemie International Edition. 50(33). 7604–7606. 23 indexed citations
4.
Donohoe, Timothy J., et al.. (2011). A Short and Efficient Synthesis of Neodysiherbaine A by Using Catalytic Oxidative Cyclization. Angewandte Chemie. 123(33). 7746–7748. 3 indexed citations
5.
Bower, John F., T. Riis‐Johannessen, Peter Szeto, Andrew J. Whitehead, & Timothy Gallagher. (2007). Stereospecific construction of substituted piperidines. Synthesis of (−)-paroxetine and (+)-laccarin. Chemical Communications. 728–730. 48 indexed citations
6.
Bower, John F., A. Williams, Hannah L. Woodward, et al.. (2007). Reactivity of cyclic sulfamidates towards phosphonate-stabilised enolates: synthesis and applications of α-phosphono lactams. Organic & Biomolecular Chemistry. 5(16). 2636–2636. 20 indexed citations
7.
Bower, John F., Peter Szeto, & Timothy Gallagher. (2007). Cyclic Sulfamidates as Precursors to Alkylidene Pyrrolidines and Piperidines. Organic Letters. 9(23). 4909–4912. 27 indexed citations
8.
Bower, John F., T. Riis‐Johannessen, Peter Szeto, Andrew J. Whitehead, & Timothy Gallagher. (2007). Stereospecific Construction of Substituted Piperidines. Synthesis of (‐)‐Paroxetine and (+)‐Laccarin.. ChemInform. 38(25). 1 indexed citations
9.
Bower, John F., Peter Szeto, & Timothy Gallagher. (2006). Cyclic sulfamidates as versatile lactam precursors. An evaluation of synthetic strategies towards (−)-aphanorphine. Organic & Biomolecular Chemistry. 5(1). 143–150. 55 indexed citations
10.
Bower, John F., Suda Chakthong, Jakub Švenda, et al.. (2006). Reactivity of cyclic sulfamidates towards sulfur-stabilised enolates. Stereocontrolled synthesis of functionalised lactams. Organic & Biomolecular Chemistry. 4(10). 1868–1877. 26 indexed citations
11.
Bower, John F., Peter Szeto, & Timothy Gallagher. (2005). Cyclic sulfamidates as lactam precursors. An efficient asymmetric synthesis of (-)-aphanorphine. Chemical Communications. 5793–5793. 45 indexed citations
12.
Sinclair, Alex, et al.. (2004). Direct Synthesis of Aliphatic Vinyl Aziridines.. ChemInform. 35(21). 1 indexed citations
13.
Stockman, Robert A., et al.. (2004). A Two‐Directional Synthesis of (.+‐.)‐Perhydrohistrionicotoxin (I).. ChemInform. 35(30). 1 indexed citations
14.
Stockman, Robert A., et al.. (2004). A Two-Directional Synthesis of (±)-Perhydrohistrionicotoxin. The Journal of Organic Chemistry. 69(5). 1598–1602. 45 indexed citations
15.
16.
Bower, John F., Jakub Švenda, A. Williams, et al.. (2004). Cyclic Sulfamidates as Vehicles for the Synthesis of Substituted Lactams. Organic Letters. 6(25). 4727–4730. 55 indexed citations
17.
Sinclair, Alex, et al.. (2004). Direct synthesis of aliphatic vinyl aziridines. Tetrahedron Letters. 45(8). 1589–1591. 29 indexed citations
18.
Szeto, Peter, et al.. (1997). Oxazaborolidine-mediated reduction of prochiral 2-alkylidene cycloalkanones. Tetrahedron Asymmetry. 8(5). 673–676. 13 indexed citations
19.
Stockman, Robert A., Peter Szeto, Stephen Thompson, et al.. (1996). Synthesis of Functionalised Azabicycles via a Regiospecific Intramolecular Aldol Reaction. Synlett. 1996(9). 853–855. 6 indexed citations
20.
Szeto, Peter, David Lathbury, & Timothy Gallagher. (1995). Heterocyclic ketones as pre-formed building blocks. Synthesis of (−)-slaframine. Tetrahedron Letters. 36(38). 6957–6960. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026